Skip to main content
Log in

Re: The calcium scare: what would Austin Bradford Hill have thought?

  • Letter to the Editor
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Nordin BE, Lewis JR, Daly RM et al. (2011) The calcium scare—what would Austin Bradford Hill have thought? Osteoporos Int. doi:10.1007/s00198-011-1680-4

  2. Bolland MJ, Avenell A, Baron JA et al (2010) Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341:c3691

    Article  PubMed  Google Scholar 

  3. Bolland MJ, Avenell A, Baron JA et al. (2010) Calcium and cardiovascular risk- author response. BMJ http://www.bmj.com/content/341/bmj.c3691/reply#bmj_el_240991. Accessed 5 Sept 2011

  4. Bolland MJ, Avenell A, Baron JA et al. (2010) Calcium and cardiovascular risk- author response to further issues. BMJ http://www.bmj.com/content/341/bmj.c3691/reply#bmj_el_240994. Accessed 5 Sept 2011

  5. Reid IR, Bolland MJ, Avenell A et al (2011) Cardiovascular effects of calcium supplementation. Osteoporos Int 22:1649–1658

    Article  PubMed  CAS  Google Scholar 

  6. Bolland MJ, Barber PA, Doughty RN et al (2008) Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336:262–266

    Article  PubMed  CAS  Google Scholar 

  7. Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300

    PubMed  CAS  Google Scholar 

  8. Demer LL (1995) A skeleton in the atherosclerosis closet. Circulation 92:2029–2032

    PubMed  CAS  Google Scholar 

  9. Ronni-Sivula H (1985) Causes of death in patients previously operated on for primary hyperparathyroidism. Ann Chir Gynaecol 74:13–18

    PubMed  CAS  Google Scholar 

  10. Palmer M, Adami HO, Bergstrom R et al (1987) Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet 1:59–62

    Article  PubMed  CAS  Google Scholar 

  11. Hedback G, Oden A (1998) Increased risk of death from primary hyperparathyroidism—an update. Eur J Clin Invest 28:271–276

    Article  PubMed  CAS  Google Scholar 

  12. Lundgren E, Lind L, Palmer M et al (2001) Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery 130:978–985

    Article  PubMed  CAS  Google Scholar 

  13. Nilsson IL, Yin L, Lundgren E et al (2002) Clinical presentation of primary hyperparathyroidism in Europe—nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res 17(Suppl 2):N68–N74

    PubMed  Google Scholar 

  14. Vestergaard P, Mollerup CL, Frokjaer VG et al (2003) Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 27:216–222

    Article  PubMed  Google Scholar 

  15. Ogard CG, Engholm G, Almdal TP et al (2004) Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977–1993 in Denmark. World J Surg 28:108–111

    Article  PubMed  Google Scholar 

  16. Bolland MJ, Grey A, Reid IR (2011) Calcium supplements and cardiovascular risk. J Bone Miner Res 26:899

    Article  PubMed  Google Scholar 

  17. Bolland MJ, Grey A, Avenell A et al (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 342:d2040

    Article  PubMed  Google Scholar 

  18. Tang BMP, Eslick GD, Nowson C et al (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370:657–666

    Article  PubMed  CAS  Google Scholar 

  19. DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group (2010) Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 340:b5463

    Article  Google Scholar 

  20. Reid IR, Bolland MJ, Grey A (2008) Effect of calcium supplementation on hip fractures. Osteoporos Int 19:1119–1123

    Article  PubMed  CAS  Google Scholar 

  21. Grant AM, Avenell A, Campbell MK et al (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 365:1621–1628

    Article  PubMed  CAS  Google Scholar 

  22. Jackson RD, LaCroix AZ, Gass M et al (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354:669–683

    Article  PubMed  CAS  Google Scholar 

  23. Prince RL, Devine A, Dhaliwal SS et al (2006) Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 166:869–875

    Article  PubMed  CAS  Google Scholar 

  24. Reid IR, Mason B, Horne A et al (2006) Randomized controlled trial of calcium in healthy older women. Am J Med 119:777–785

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. J. Bolland.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bolland, M.J., Grey, A. & Reid, I.R. Re: The calcium scare: what would Austin Bradford Hill have thought?. Osteoporos Int 22, 3079–3080 (2011). https://doi.org/10.1007/s00198-011-1783-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-011-1783-y

Keywords

Navigation